Sale!

MT-ATP8 Gene Cardiomyopathy infantile hypertrophic MT-ATP8 related Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The “MT-ATP8 Gene Cardiomyopathy Infantile Hypertrophic MT-ATP8 Related Genetic Test” is a specialized diagnostic procedure aimed at identifying mutations in the MT-ATP8 gene, which have been linked to the development of infantile hypertrophic cardiomyopathy. This condition is a severe form of heart disease that manifests early in life, leading to the thickening of the heart’s walls and potentially resulting in heart failure or sudden death if not diagnosed and managed promptly. The test is particularly crucial for families with a history of the condition or when the disease is suspected based on clinical symptoms.

Performed at DNA Labs UAE, a leading genetic testing facility, the test involves analyzing the patient’s DNA to detect mutations in the MT-ATP8 gene that are responsible for the condition. This gene plays a critical role in the production of ATP synthase, an enzyme vital for energy production within heart muscle cells. Mutations can impair heart function, leading to the symptoms associated with hypertrophic cardiomyopathy.

The cost of the test is 4400 AED, reflecting the sophisticated technology and expertise required to accurately identify the genetic mutations associated with this condition. By opting for this test, patients and their families can gain valuable insights into the genetic basis of the disease, enabling targeted treatment strategies and informed decisions about management and care. Early detection through genetic testing like the MT-ATP8 related test is essential for improving outcomes and quality of life for affected infants.

Description

MT-ATP8 Gene Cardiomyopathy Infantile Hypertrophic MT-ATP8 Related Genetic Test

Test Name: MT-ATP8 Gene Cardiomyopathy Infantile Hypertrophic MT-ATP8 Related Genetic Test

Components: Blood or Extracted DNA or One drop Blood on FTA Card

Price: 4400.0 AED

Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card

Report Delivery: 3 to 4 Weeks

Method: NGS Technology

Test Type: Cardiovascular Pneumology Disorders

Doctor: Cardiologist

Test Department: Genetics

Pre Test Information: Clinical History of Patient who is going for MT-ATP8 Gene Cardiomyopathy, infantile hypertrophic, MT-ATP8 related NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with MT-ATP8 Gene Cardiomyopathy, infantile hypertrophic, MT-ATP8 related NGS Genetic DNA Test gene MT-ATP8

Test Details: MT-ATP8 gene cardiomyopathy, also known as infantile hypertrophic cardiomyopathy, is a genetic disorder that affects the heart muscle. It is caused by mutations in the MT-ATP8 gene, which is involved in the production of energy in the mitochondria. Infantile hypertrophic cardiomyopathy is characterized by thickening of the heart muscle, leading to reduced pumping ability and other heart-related problems. Symptoms usually appear in infancy or early childhood and can include difficulty breathing, poor feeding, failure to thrive, and an enlarged heart.

To diagnose MT-ATP8 gene cardiomyopathy, a genetic test called Next-Generation Sequencing (NGS) can be performed. NGS is a high-throughput method that can analyze multiple genes simultaneously, allowing for the detection of mutations in the MT-ATP8 gene and other genes associated with cardiomyopathy. NGS genetic testing involves obtaining a sample of DNA, usually through a blood sample or saliva sample, and sequencing the DNA to identify any mutations or variations in the MT-ATP8 gene. This can help confirm a diagnosis of MT-ATP8 gene cardiomyopathy and provide information about the specific mutation involved.

Genetic testing can be useful for confirming a diagnosis, guiding treatment decisions, and providing information about the risk of passing the condition on to future generations. It can also help with genetic counseling and family planning. It is important to consult with a healthcare professional or genetic counselor to discuss the appropriateness and implications of genetic testing for MT-ATP8 gene cardiomyopathy. They can provide more detailed information about the specific test, its limitations, and the potential benefits and risks involved.

Test Name	MT-ATP8 Gene Cardiomyopathy infantile hypertrophic MT-ATP8 related Genetic Test
Components
Price	4400.0 AED
Sample Condition	Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery	3 to 4 Weeks
Method	NGS Technology
Test type	Cardiovascular Pneumology Disorders
Doctor	Cardiologist
Test Department:	Genetics
Pre Test Information	Clinical History of Patient who is going for MT-ATP8 Gene Cardiomyopathy, infantile hypertrophic, MT-ATP8 related NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with MT-ATP8 Gene Cardiomyopathy, infantile hypertrophic, MT-ATP8 related NGS Genetic DNA Test gene MT-ATP8
Test Details	MT-ATP8 gene cardiomyopathy, also known as infantile hypertrophic cardiomyopathy, is a genetic disorder that affects the heart muscle. It is caused by mutations in the MT-ATP8 gene, which is involved in the production of energy in the mitochondria. Infantile hypertrophic cardiomyopathy is characterized by thickening of the heart muscle, leading to reduced pumping ability and other heart-related problems. Symptoms usually appear in infancy or early childhood and can include difficulty breathing, poor feeding, failure to thrive, and an enlarged heart. To diagnose MT-ATP8 gene cardiomyopathy, a genetic test called Next-Generation Sequencing (NGS) can be performed. NGS is a high-throughput method that can analyze multiple genes simultaneously, allowing for the detection of mutations in the MT-ATP8 gene and other genes associated with cardiomyopathy. NGS genetic testing involves obtaining a sample of DNA, usually through a blood sample or saliva sample, and sequencing the DNA to identify any mutations or variations in the MT-ATP8 gene. This can help confirm a diagnosis of MT-ATP8 gene cardiomyopathy and provide information about the specific mutation involved. Genetic testing can be useful for confirming a diagnosis, guiding treatment decisions, and providing information about the risk of passing the condition on to future generations. It can also help with genetic counseling and family planning. It is important to consult with a healthcare professional or genetic counselor to discuss the appropriateness and implications of genetic testing for MT-ATP8 gene cardiomyopathy. They can provide more detailed information about the specific test, its limitations, and the potential benefits and risks involved.